| Firm | Analyst | |
|---|---|---|
|
Barclays
|
Etzer Darout | etzer.darout@barclays.com |
|
BTIG
|
Julian Harrison | jharrison@btig.com |
|
Citizens JMP Securities
|
Jason Butler | jbutler@jmpsecurities.com |
|
Goldman Sachs
|
Rajan Sharma | rajan.sharma@gs.com |
|
Guggenheim
|
Yatin Suneja | Yatin.Suneja@guggenheimpartners.com |
|
Jefferies
|
Faisal Khurshid | fkhurshid@jefferies.com |
|
Kempen
|
Sebastiaan van der Schoot | sebastiaan.vanderschoot@kempen.com |
|
Kepler Cheuvreux
|
Justine Telliez | jtelliez@keplercheuvreux.com |
|
Laidlaw
|
Yale Jen | YJen@laidlawltd.com |
|
Leerink
|
Thomas Smith | Thomas.Smith@leerink.com |
|
LifeSci Capital | Alpha Series
|
Sam Slutsky | SSlutsky@lifescicapital.com |
|
Morgan Stanley
|
Judah Frommer | judah.frommer@morganstanley.com |
|
Oddo BHF
|
Martial Descoutures | martial.descoutures@oddo-bhf.com |
|
Piper Sandler
|
Allison Bratzel | allison.bratzel@psc.com |
|
Stifel
|
Damien Choplain | damien.choplain@stifel.com |
|
Truist
|
Gregory Renza | gregory.renza@truist.com |
|
Wedbush
|
David Nierengarten | david.nierengarten@wedbush.com |
|
Wolfe Research
|
Andy Chen | achen@wolferesearch.com |
Abivax is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Abivax's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Abivax or its management. Abivax does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.